platelet aggregation
Conditions
Interventions
Patients population:Nil
Sponsors
Chinese PLA General Hospital
Eligibility
Sex/Gender
All
Age
50 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1. Aged 50~90 years old men or non-pregnant, non-lactating women; 2. Check with the annual health examination synchronization, and have no found any disease need to treat . 3. The body is basically healthy no cancer and other infectious diseases; 4. Patients agreed to accept the program and signed informed consent, The history of data collection and the follow-up process can be saved.
Exclusion criteria
Exclusion criteria: 1. Fainting patients; 2. Disability, obviously unhealthy or sick; 3. Patients with more serious heart, liver, kidney dysfunction, total bilirubin higher than normal , AST or ALT higher thannormal; 4. Associated with lung infection, or severe systemic infected; 5. History of serious allergic reactions or two or more kinds of food or drug allergies, and within six months of various immunization history; 6. Nervous system disorders or poor psychological status (including epilepsy, depression and other psychiatric history, etc.); 7. Patients can be sure with serum HIV-positive, syphilis antibody positive, hepatitis B, hepatitis C or other severe infectious diseases; 8. Patients with severe mental illness, cognitive dysfunction, or patients can not be understood and signed the informed consent; 9. The volunteers who had coagulation disorders,using anticoagulants or intended to use; 10. Volunteers participated in other clinical researchers within three months; 11. The volunteers had installed heart, cerebrovascular stent or pacemaker; 12. Volunteers who were undergone surgery ,bruises and trauma (including fractures) within the past month; 13. After the test will change the varieties and dosage of anti-platelet drug , including the use of traditional Chinese medicine and ginseng, Salvia and other health products; 14. Pregnancy, trauma, surgery, and other diseases that are obviously unrelated to this trial occur during the trial; 15. Judged by a doctor, the volunteers are not suitable for clinical studies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Platelet aggregation; | — |
Countries
China
Contacts
Public ContactYulong Cong
Chinese PLA General Hospital
Outcome results
None listed